"Discrimination is newly legal," Breitenstein said of the Trump administration's retraction of protections for transgender patients. In the coming years, Breitenstein sees Folx drastically expanding the conditions it is able to treat through telemedicine in addition to expanding into owned-and-operated in-person clinics across the country. Breitenstein told Business Insider of her long-term goals to unseat traditional care avenues for the LGBTQIA+ community, which is often discriminated against in traditional primary care settings.
#Folx hormones series
On Tuesday, Folx announced it raised $25 million in Series A funding from Bessemer Venture Partners, Polaris Partners, Define Ventures, and Red Antler.Īlthough Folx is launching with direct-mail hormone replacement therapy treatments for transgender patients, founder and CEO A.G. One such startup is Folx, a consumer healthcare startup for LGBTQIA+ patients, although there are tens more startups hoping to build trust among other long-neglected and underserved communities of patients. Primary care, and healthcare more broadly, is largely one-size-fits-all in the US.Ī growing group of entrepreneurs and investors are trying to dismantle it and rebuild a more equitable healthcare system in its wake. Visit Business Insider's homepage for more stories.Primary care startups serving specific populations instead of a more generalist audience have raised more than $1 billion in the last several years, according to Pitchbook data.The startup provides telemedicine visits for LGBTQIA+ patients in addition to mailed hormone replacement therapy for transgender patients.Folx, a consumer healthcare startup for LGBTQIA+ patients, raised $25 million in Series A funding from Bessemer Venture Partners, the company said on Tuesday.Account icon An icon in the shape of a person's head and shoulders.
0 kommentar(er)
